Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
The American Journal of Surgical Pathology|August 7, 2018
Concordance of "Case Level" Global, Highest, and Largest Volume Cancer Grade Group on Needle Biopsy Versus Grade Group on Radical ProstatectomyKiril Trpkov, Sakkarn Sangkhamanon, Asli Yilmaz, et al.
Future Cardiology|October 10, 2025
Intraoperative urothelial carcinoma tumor thrombus embolization to the heart: a case reportFriederike I Schoettler, Mortaza Fatehi Hassanabad, Nicole A Webb, et al.
Histopathology|August 8, 2022
Extrarenal renal cell carcinoma arising in the kidney proximity but without an identifiable renal primary - an intriguing dilemma: report of three cases and review of the literatureMehdi Mansoor, Morgan Young-Speirs, Bing Ren, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 23, 2018
Testosterone suppression in the treatment of recurrent or metastatic prostate cancer - A Canadian consensus statementLaurence Klotz, Bobby Shayegan, Chantal Guillemette, et al.
Cancers|December 29, 2020
Social Jetlag and Prostate Cancer Incidence in Alberta's Tomorrow Project: A Prospective Cohort StudyLiang Hu, Andrew Harper, Emily Heer, et al.
International Journal of Molecular Sciences|November 11, 2022
The Association between Cyclin Dependent Kinase 2 Associated Protein 1 (CDK2AP1) and Molecular Subtypes of Lethal Prostate CancerYaser Gamallat, Andrea Bakker, Ealia Khosh Kish, et al.
BMJ Open|April 22, 2021
Virtual care for prostate cancer survivorship: protocol for an evaluation of a nurse-led algorithm-enhanced virtual clinic implemented at five cancer centres across CanadaQuynh Pham, Jason Hearn, Jacqueline L Bender, et al.
The Journal of Urology|November 16, 2010
Prognostic impact of muscular venous branch invasion in localized renal cell carcinoma casesAndrew Feifer, Caroline Savage, Heidi Rayala, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 23, 2020
Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiCGeoffrey Gotto, Darrel E Drachenberg, Joseph Chin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 1, 2019
Management algorithms for metastatic prostate cancerShawn Malone, Bobby Shayegan, Naveen S Basappa, et al.
Pageof 3